Hey there! Welcome!
Get updated on
Select Speciality
Top Picks
24 Jun, 26
ECO 2026
Key sessions presented presented at 33rd European Congress on Obesity held at Istanbul, Türkey.
24 Jun, 26ECO 2026
Key sessions presented presented at 33rd European Congress on Obesity held at Istanbul, Türkey.
25 Jun, 26Int. J. Infect. Dis.
- Antibiotics for uncomplicated sore throat prevent few invasive Group A Streptococcus (iGAS) cases (≤6.7% children, ≤2.8% adults).
- Targeted strategy prevents even fewer cases (≤1.6% children, ≤1.2% adults).
- Very high number needed to treat (NNT)(12,000–110,000) and swabs needed (45,000–110,000) to prevent one iGAS case.
- Routine antibiotic use not justified due to minimal benefit, adverse effects, and increased w...
25 Jun, 26Cardiovasc Diabetol.
- TyG-KDM-BA index, integrating metabolic dysfunction (TyG index) & biological aging (KDM-BA), predicted CVD risk in CKM stages 0–3
- Each 1 SD rise in TyG-KDM-BA was linked to higher risk of CVD in UKB cohort (HR per 1-SD=1.65) & CHARLS cohort (HR=1.25)
- Higher quartiles showed elevated risk (UKB HR=3.97; CHARLS HR=1.92)
- AUC 0.657–0.659 indicated superior discrimination vs conventional indices, validated externally.
23 Jun, 26J Asthma Allergy
- PERFORM, a 52-week pragmatic randomized trial, showed that once-daily single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) significantly improved lung function (FEV1 change: +178 mL vs +110 mL; difference: +68 mL) and asthma control (ACQ-7 responders: 79.0% vs 71.8%) at 24 weeks vs usual ICS/LABA care in adults with uncontrolled asthma.
- Safety was comparable to prior studies.
18 Jun, 26Lancet Infect Dis
- Non-ventilator hospital-acquired pneumonia (NV-HAP) is under targeted but common HAI.
- Multicentre cluster RCT (n=8870) evaluated enhanced oral care vs usual care.
- Enhanced oral care reduced NV HAP reduced (0.7% vs 1.0%).
- Education and feedback improved care delivery.
25 Jun, 26
Featured
Slide Library
22 Jun, 26
22 Jun, 26
15 Jun, 26
Key Trials
11 Jun, 26
11 Jun, 26
